| Target Price | €42.84 |
| Price | €39.55 |
| Potential | 8.32% |
| Number of Estimates | 24 |
| 24 Analysts have issued a price target Fresenius Medical Care 2027 . The average Fresenius Medical Care target price is €42.84. This is 8.32% higher than the current stock price. The highest price target is €67.20 69.91% , the lowest is €21.94 44.52% . | |
| A rating was issued by 29 analysts: 6 Analysts recommend Fresenius Medical Care to buy, 11 to hold and 12 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
| Analyst Estimates: Analysts believe that the Fresenius Medical Care stock has an average upside potential 2027 of 8.32% . Most analysts recommend the Fresenius Medical Care stock at Sale. |
23 Analysts have issued a sales forecast Fresenius Medical Care 2026 . The average Fresenius Medical Care sales estimate is
This results in the following potential growth metrics:
19 Analysts have issued an Fresenius Medical Care EBITDA forecast 2026. The average Fresenius Medical Care EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
22 Fresenius Medical Care Analysts have issued a net profit forecast 2026. The average Fresenius Medical Care net profit estimate is
This results in the following potential growth metrics and future Net Margins:
22 Analysts have issued a Fresenius Medical Care forecast for earnings per share. The average Fresenius Medical Care EPS is
This results in the following potential growth metrics and future valuations:
Fresenius Medical Care...
| Analyst | Rating | Action | Date |
|---|---|---|---|
| BERENBERG |
Buy
➜
Buy
|
Unchanged | Sep 21 2026 |
| ODDO BHF |
Buy
➜
Buy
|
Unchanged | Sep 04 2026 |
| INTESA SANPAOLO EQUITY RESEARCH |
Buy
➜
Buy
|
Unchanged | Aug 31 2026 |
| BNP PARIBAS |
Neutral
➜
Underperform
|
Downgrade | Aug 31 2026 |
| METZLER EQUITIES |
Hold
➜
Hold
|
Unchanged | Aug 28 2026 |
| LANDESBANK BADEN-WUERTTEMBERG |
Buy
➜
Buy
|
Unchanged | Aug 26 2026 |
| TRUIST SECURITIES |
Hold
➜
Hold
|
Unchanged | Aug 25 2026 |
| Analyst Rating | Date |
|---|---|
|
Unchanged
BERENBERG:
Buy
➜
Buy
|
Sep 21 2026 |
|
Unchanged
ODDO BHF:
Buy
➜
Buy
|
Sep 04 2026 |
|
Unchanged
INTESA SANPAOLO EQUITY RESEARCH:
Buy
➜
Buy
|
Aug 31 2026 |
|
Downgrade
BNP PARIBAS:
Neutral
➜
Underperform
|
Aug 31 2026 |
|
Unchanged
METZLER EQUITIES:
Hold
➜
Hold
|
Aug 28 2026 |
|
Unchanged
LANDESBANK BADEN-WUERTTEMBERG:
Buy
➜
Buy
|
Aug 26 2026 |
|
Unchanged
TRUIST SECURITIES:
Hold
➜
Hold
|
Aug 25 2026 |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.


